ВестникНОМУС
.
Сборникматериалов
конкурса
литературных
обзоров
-2012
14
37.
The ESHRE Capri Workshop Group. Ovarian and endometrial function
duringhormonal contraception. HumReprod2001; 16: 1527–35.
38.
Ness RB, Griss JA, Klapper J et al., and the SHARE StudyGroup. Rick
of ovarian cancer in relation to estrogen and progestin dose and use characteristics of
oral contraceptives. Am J Epidemiol 2000; 152: 233–41.
39.
Wise LA, Palmer JR, Harlow BL et al. Reproductive factors, hormonal
contraception and risk of uterine leiomyomata in African-American women: a
prospective study. Am J Epidemiol 2004; 159: 113–23.
40.
Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the
uterus and the endometrium: low prevalence of leiomyoma in a random sample of
women aged25–40 years. ActaObstet Gynecol Scand2000; 79: 202–7.
41.
Sulak PJ. Oral contraceptives. Therapeutic uses quality-of-life benefits –
case presentations. Contraception 1999; 59: 355–85.
42.
KuohungW, Borga TTA, Stubblefield P. Low-dose oral contraceptives
and bone mineral density: an evidence-based approach. Contraception 2000; 61: 77–
8.
43.
Petitti DB, PiaggioG, Mehta S et al. Steroid hormone contraception and
bone mineral density: a cross-sectional study in an international population. Obstet
Gynecol 2000; 95: 736–44.
44.
Reed SD, Scholes D, LaCroix AZ et al. Longitudinal changes in bone
density in relation to oral contraceptive use. Contraception 2003; 68: 177–82.
45.
Nappi C, Di Spiezio SardoA, AcunzoG et al. Effects of a low-dose and
ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral
density in young fertile women: a prospective controlled randomized study.
Contraception2003; 67: 355–59.
46.
Endrikat J, Mih E, Dusterberg K et al. A 3-year double-blind
randomized controlled study on the influence of two oral contraceptives containing
either 20 µg or 30 µg ethinylestradiol in combination with levonorgestrel on bone
mineral density. Contraception 2004; 69: 179–87.
47.
Doppler study / S. Tanawattankcharoen, K. Panyakhamlerd, S.
Chaikittisilpa, N. Taechakraichana,
К
. K. Limpaphayom // J.Med. Assoc. Thai. 2000.
-Apr;83(4).-P. 368-373.
48.
Castelo-Branco C, Vicente JJ, Pons F et al. Bone mineral density in
young, hypothalamic oligomenorrheic women treated with oral contraceptives. J
ReprodMed2001; 46: 875–79.
49.
Gordon CM, Grace E, Emans SJ et al. Effects of oral
dehydroepiandrosterone on bone density in young women with anorexia nervosa. J
ClinEndocrinolMetab 2002; 87: 4935–41.
50.
Munoz MT, Morande G, Garcia-Centenera JA et al. The effects of
estrogen administration on bone mineral density in adolescents with anorexia
nervosa. Eur J Endocrinol 2002; 146: 45–50.
51.
Grinspoon S, Thomas L, Miller K et al. Effects of recombinant human
IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J
ClinEndocrinolMetab 2002; 87: 2883–91.
